Form 4: BioCardia CEO Peter Altman Acquires Shares in Open Market Transaction

BioCardia's President and CEO, Peter Altman, purchased 250 shares of common stock at an average price of $2.22 per share on December 5, 2024.

Summary

• Peter Altman, the President and CEO of BioCardia, Inc., acquired 250 shares of the company's common stock on December 5, 2024.
• The shares were purchased at a weighted average price of $2.22, with individual trades ranging from $2.17 to $2.24 per share.
• Following this transaction, Mr. Altman directly owns 105,581 shares of BioCardia common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is a positive sign, but the transaction is small and routine.

Positives

• The CEO's purchase of shares could be seen as a positive signal of confidence in the company's future prospects.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading activity.
• There are no specific industry benchmarks to compare this transaction to, as it is an individual purchase by an executive.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

BioCardia, Peter Altman, stock purchase, insider trading, common stock, executive, share acquisition